269 related articles for article (PubMed ID: 34928716)
1. Dual Transcriptomics To Determine Gamma Interferon-Independent Host Response to Intestinal Cryptosporidium parvum Infection.
Gallego-Lopez GM; Mendoza Cavazos C; Tibabuzo Perdomo AM; Garfoot AL; O'Connor RM; Knoll LJ
Infect Immun; 2022 Feb; 90(2):e0063821. PubMed ID: 34928716
[TBL] [Abstract][Full Text] [Related]
2. MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice.
Rogers KA; Rogers AB; Leav BA; Sanchez A; Vannier E; Uematsu S; Akira S; Golenbock D; Ward HD
Infect Immun; 2006 Jan; 74(1):549-56. PubMed ID: 16369011
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.
Tessema TS; Schwamb B; Lochner M; Förster I; Jakobi V; Petry F
Immunobiology; 2009; 214(6):454-66. PubMed ID: 19155092
[TBL] [Abstract][Full Text] [Related]
4. Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection.
Theodos CM; Sullivan KL; Griffiths JK; Tzipori S
Infect Immun; 1997 Nov; 65(11):4761-9. PubMed ID: 9353062
[TBL] [Abstract][Full Text] [Related]
5. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection.
Lacroix S; Mancassola R; Naciri M; Laurent F
Infect Immun; 2001 Mar; 69(3):1635-42. PubMed ID: 11179338
[TBL] [Abstract][Full Text] [Related]
6. Interferon-λ3 Promotes Epithelial Defense and Barrier Function Against Cryptosporidium parvum Infection.
Ferguson SH; Foster DM; Sherry B; Magness ST; Nielsen DM; Gookin JL
Cell Mol Gastroenterol Hepatol; 2019; 8(1):1-20. PubMed ID: 30849550
[TBL] [Abstract][Full Text] [Related]
7. Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection.
Lacroix-Lamandé S; Mancassola R; Naciri M; Laurent F
Infect Immun; 2002 Apr; 70(4):2090-9. PubMed ID: 11895975
[TBL] [Abstract][Full Text] [Related]
8. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
[TBL] [Abstract][Full Text] [Related]
9. Cytokine expression and specific lymphocyte proliferation in two strains of Cryptosporidium parvum-infected gamma-interferon knockout mice.
Smith LM; Bonafonte MT; Mead JR
J Parasitol; 2000 Apr; 86(2):300-7. PubMed ID: 10780549
[TBL] [Abstract][Full Text] [Related]
10. Roles for NK cells and an NK cell-independent source of intestinal gamma interferon for innate immunity to Cryptosporidium parvum infection.
Barakat FM; McDonald V; Di Santo JP; Korbel DS
Infect Immun; 2009 Nov; 77(11):5044-9. PubMed ID: 19687195
[TBL] [Abstract][Full Text] [Related]
11. IL-4 protects adult C57BL/6 mice from prolonged Cryptosporidium parvum infection: analysis of CD4+alpha beta+IFN-gamma+ and CD4+alpha beta+IL-4+ lymphocytes in gut-associated lymphoid tissue during resolution of infection.
Aguirre SA; Perryman LE; Davis WC; McGuire TC
J Immunol; 1998 Aug; 161(4):1891-900. PubMed ID: 9712058
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice.
McDonald V; Deer R; Uni S; Iseki M; Bancroft GJ
Infect Immun; 1992 Aug; 60(8):3325-31. PubMed ID: 1639500
[TBL] [Abstract][Full Text] [Related]
13. Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.
Jenkins MC; O'Brien C; Trout J; Guidry A; Fayer R
Vaccine; 1999 May; 17(19):2453-60. PubMed ID: 10392628
[TBL] [Abstract][Full Text] [Related]
14. Characterization of experimental Cryptosporidium parvum infection in IFN-gamma knockout mice.
You X; Mead JR
Parasitology; 1998 Dec; 117 ( Pt 6)():525-31. PubMed ID: 9881376
[TBL] [Abstract][Full Text] [Related]
15. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice.
Smith LM; Bonafonte MT; Campbell LD; Mead JR
Exp Parasitol; 2001 Jul; 98(3):123-33. PubMed ID: 11527435
[TBL] [Abstract][Full Text] [Related]
16. Cryptosporidium parvum: the course of Cryptosporidium parvum infection in C57BL/6 mice co-infected with the nematode Heligmosomoides bakeri.
Bednarska M; Bajer A; Sinski E
Exp Parasitol; 2008 Sep; 120(1):21-8. PubMed ID: 18522859
[TBL] [Abstract][Full Text] [Related]
17. Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity.
Ungar BL; Kao TC; Burris JA; Finkelman FD
J Immunol; 1991 Aug; 147(3):1014-22. PubMed ID: 1677668
[TBL] [Abstract][Full Text] [Related]
18. Humoral immune response in IL-12 and IFN-gamma deficient mice after infection with Cryptosporidium parvum.
Jakobi V; Petry F
Parasite Immunol; 2008 Mar; 30(3):151-61. PubMed ID: 18179628
[TBL] [Abstract][Full Text] [Related]
19. Cryptosporidium parvum: the contribution of Th1-inducing pathways to the resolution of infection in mice.
Ehigiator HN; McNair N; Mead JR
Exp Parasitol; 2007 Feb; 115(2):107-13. PubMed ID: 16920103
[TBL] [Abstract][Full Text] [Related]
20. Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection.
Robinson P; Okhuysen PC; Chappell CL; Lewis DE; Shahab I; Lahoti S; White AC
Cytokine; 2001 Jul; 15(1):39-46. PubMed ID: 11509007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
